HUTCHMED has issued a total of 866,161,450 ordinary shares. Each Nasdaq-listed American Depositary Share (ADS) equates to five ordinary shares.
For illustrative purposes only, if converted in their entirety, this would be equivalent to 173,232,290 Nasdaq-traded ADSs.
Insofar as HUTCHMED is aware, approximately 40.35% of the issued share capital of HUTCHMED is not in public hands. Such percentage comprises the shares held by Directors, Executive Officers, and CK Hutchison Holdings Limited, a significant shareholder of HUTCHMED.
The disclosure of certain major and significant shareholdings in the share capital of HUTCHMED is governed by (i) the provisions of rule 5 of the Disclosure Guidance and Transparency Rules of the U.K. Financial Conduct Authority (DTR) (which have been incorporated by reference into the Company's Articles of Association); (ii) the US Securities Exchange Act of 1934; and (iii) the Hong Kong Securities and Futures Ordinance (Cap. 571).
Insofar as HUTCHMED is aware, the interests of its shareholders holding 3% or more of the issued share capital of HUTCHMED and its directors (as of December 31, 2022) are set out in the tables below.
Last updated: May 17, 2023
|Name||Total Number of Shares Held / Interested||Approx. % of Total Issued Shares|
|CK Hutchison Holdings Limited (1)||332,574,650||38.46%|
|The Capital Group Companies, Inc. (2)||40,718,761||4.71%|
|M&G Plc (3)||32,648,956||3.78%|
|The Goldman Sachs Group, Inc.(4)||42,554,228||4.92%|
|CA Fern Parent (5)(6)||40,847,500||4.72%|
|Name||Total Number of Shares/Underlying Shares Held||Approx. % of Total Issued Shares|